These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4844125)

  • 21. [Unlimited usefulness of the intravenous tolbutamide test in the early diagnosis of over 45-year-old diabetics].
    Schneider H; Wache HW
    Z Gesamte Inn Med; 1970 Dec; 25(24):1133-5. PubMed ID: 5520027
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia-antigen in patients with acute and chronic liver diseases].
    Nielsen PE; Nielsen JO; Dietrichson O
    Ugeskr Laeger; 1970 May; 132(19):875-9. PubMed ID: 5447319
    [No Abstract]   [Full Text] [Related]  

  • 23. [Factors affecting the activity of laboratory thromboplastin].
    Kokoulin BE; Tarasova LN; Nosov PA
    Lab Delo; 1971; 6():341-3. PubMed ID: 4108746
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver of the diabetic patient. Functional and histological findings].
    Gambigliani-Zoccoli A; Comoli G
    G Clin Med; 1968 Jan; 49(1):18-55. PubMed ID: 5736617
    [No Abstract]   [Full Text] [Related]  

  • 25. M-components in patients with chronic liver disease.
    Ellman LL; Pachas WN; Pinals RS; Bloch KJ
    Gastroenterology; 1969 Aug; 57(2):138-42. PubMed ID: 5799671
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetics of tolbutamide metabolism in humans.
    Scott J; Poffenbarger PL
    Diabetes; 1979 Jan; 28(1):41-51. PubMed ID: 569611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The serum tolbutamide picture during oral treatment of diabetes].
    Leubner H; Saito S
    Wien Klin Wochenschr; 1970 May; 82(18):321-4. PubMed ID: 4930124
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blood volume].
    Schmidt HA
    Ergeb Inn Med Kinderheilkd; 1968; 27():155-249. PubMed ID: 4883771
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interaction of phenylbutazone and tolbutamide in man].
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of gamma glutamyl transpeptidase and the mean corpuscular volume in chronic hepatitis of alcoholic etiology].
    Pasqualetti P; Festuccia V; MacCarone C; Di Lauro G; Casale R
    Minerva Med; 1995 Oct; 86(10):395-402. PubMed ID: 8622806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolbutamide kinetics in a normal Indian population.
    Uppal R; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):95-6. PubMed ID: 3988400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous tolbutamide loading test in cytostatic treatment with cyclophosphamide].
    Lawonn H
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(3):275-8. PubMed ID: 5203545
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease.
    Pereira SP; Rowbotham D; Fitt S; Shearer MJ; Wendon J; Williams R
    J Hepatol; 2005 Mar; 42(3):365-70. PubMed ID: 15710219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Volume distribution curves and mean diameters of erythrocytes in various diseases].
    Kallee E; Wechselberger E
    Arztl Forsch; 1971 Dec; 25(12):381-95. PubMed ID: 5171709
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
    [No Abstract]   [Full Text] [Related]  

  • 39. [A study of factors effecting on an observation time needed for outpatient treatment of acute alcohol intoxication in Japan].
    Okamoto H; Ushida S; Ishimatsu S; Teruya K; Tsunoda T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Apr; 39(2):136-44. PubMed ID: 15160891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.